LAUREN STRINGER: Open Payments
NPI 1750006623 · OCALA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$808 in 28 payments from 9 companies in 2025. Trend: 2023 $524 · 2024 $540 · 2025 $808
Food & beverage: $790Education: $17
| Company | Payments | Amount |
|---|---|---|
| Insmed, Inc. | 16 | $356 |
| REVANCE THERAPEUTICS, INC. | 1 | $100 |
| Theratechnologies Inc. | 2 | $96 |
| Smith+Nephew, Inc. | 2 | $69 |
| Merck Sharp & Dohme LLC | 2 | $64 |
| Aimmune Therapeutics, Inc. | 2 | $45 |
| Organogenesis Inc. | 1 | $37 |
| ViiV Healthcare Company | 1 | $26 |
| Gilead Sciences, Inc. | 1 | $15 |
Products named: Arikayce, DAXXIFY, EGRIFTA, RENASYS TOUCH, ZERBAXA, VOWST, AFFINITY, CABENUVA.
Industry payments across FL — which companies pay providers there.
